Maximum quantity allowed is 999
请选择数量
CAS RN: 81129-83-1 | 产品编码: C3547
Cilastatin Sodium Salt

纯度/分析方法: >97.0%(HPLC)
别名:
- 西司他丁钠
- (R)-2-氨基-3-[[(Z)-6-羧基-6-[(S)-2,2-二甲基环丙烷甲酰胺]己-5-烯-1-基]硫代]丙酸单钠盐
- Monosodium (R)-2-Amino-3-[[(Z)-6-carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-en-1-yl]thio]propanoate
- (R)-2-Amino-3-[[(Z)-6-carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-en-1-yl]thio]propanoic Acid Monosodium Salt
产品文档:
技术规格
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Nonaqueous Titration) | min. 95.0 % |
NMR | confirm to structure |
物性(参考值)
GHS
相关法规
RTECS# | MJ9650200 |
运输信息
HS编码* | 2941.90-000 |
应用
Cilastatin Sodium: A Dehydropeptidase-I Inhibitor
Cilastatin sodium is a dehydropeptidase-I inhibitor that prevents renal metabolism and increases urinary excretion of bioactive agents, such as imipenem. Therefore, cilastatin sodium is often used in combination with imipenem. (The product is for research purpose only.)
References
- Inhibition of the mammalian β-lactamase renal dipeptidase (dehydropeptidase-I) by Z-2-(acylamino)-3-substituted-propenoic acids
- The renal membrane dipeptidase (dehydropeptidase I) inhibitor, cilastatin, inhibits the bacterial metallo-β-lactamase enzyme CphA
- Thienamycin: development of imipenen-cilastatin (a review)
- Hydrophilic interaction chromatography/tandem mass spectrometry for the simultaneous determination of three polar non-structurally related compounds, imipenem, cilastatin and an investigational β-lactamase inhibitor, MK-4698, in biological matrices
技术文章
产品文档 (部分产品的分析图谱无法提供,敬请谅解。)
化学品安全说明书(SDS)
请选择语言。
如需更多帮助,请联系我 们。
技术规格
CoA及其他文档
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
示例 CoA
可下载CoA示例。注:该示例不一定是最新批次的CoA。
目前没有该产品的 CoA 示例。
分析图谱
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
很抱歉,您搜索的分析图谱无法提供。